KYMR vs AMGN: Which Stock is Better?
Side-by-side comparison of Kymera Therapeutics Inc and Amgen Inc in 2026
KYMR
Kymera Therapeutics Inc
$87.71
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | KYMR | AMGN | Winner |
|---|---|---|---|
| Market Cap | $7.16B | $191.53B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.46 | AMGN |
| Revenue Growth | -0.6% | 0.1% | AMGN |
| Gross Margin | -707.3% | 70.8% | AMGN |
Analyze KYMR
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KYMR or AMGN a better investment?
Comparing KYMR and AMGN: Kymera Therapeutics Inc has a market cap of $7.16B while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KYMR and AMGN?
KYMR (Kymera Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KYMR or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KYMR or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.6% for KYMR.
Which company is more profitable: KYMR or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -707.3% for KYMR.
Which is the larger company: KYMR or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $7.16B for KYMR.
Should I buy KYMR or AMGN in 2026?
Both KYMR and AMGN have investment merit. KYMR trades at $87.71 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KYMR and AMGN stock?
Key differences: Market Cap ($7.16B vs $191.53B), P/E Ratio (N/A vs 24.6x), Revenue Growth (-0.6% vs 0.1%), Gross Margin (-707.3% vs 70.8%).